BioCardia, Inc. (BCDAW) Financials
BCDAW Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 3.7 million | 4.4 million |
2023-06-30 | 6.4 million | 4.8 million |
2023-03-31 | 7.1 million | 5.2 million |
2022-12-31 | 9.8 million | 4.9 million |
BCDAW Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.4 million | 251000 |
2023-06-30 | -3.2 million | 317000 |
2023-03-31 | -2.6 million | 278000 |
2022-12-31 | -3.0 million | 280000 |
BCDAW Net Income
No data available :(
BCDAW Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 1.8 million | - | 1.4 million |
2023-06-30 | 4.3 million | - | 1.5 million |
2023-03-31 | 4.9 million | - | 1.6 million |
2022-12-31 | 7.4 million | - | 1.6 million |
BCDAW Shares Outstanding
BCDAW Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.9 million | 1.1 million | - |
2023-06-30 | 2000 | 2.3 million | 1.2 million | - |
2023-03-31 | 10000 | 2.4 million | 1.2 million | - |
2022-12-31 | 2000 | 2.2 million | 924000 | - |
BCDAW Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 357000 | 104000 |
2023-06-30 | 43000 | 101000 |
2023-03-31 | 64000 | 101000 |
2022-12-31 | 106000 | 11.9 million |
BCDAW
Price: $0.01
52 week price:
Earnings Per Share: -3.20 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 9104
Market Capitalization: 4.4 million